Hisamitsu America, Marketers of the Salonpas Line of Pain Relieving Products, Announce Availability of the Salonpas Pain Relief Patch LARGE in a New, Double-Size Value Pack


FLORHAM PARK, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Hisamitsu America, a division of Hisamitsu Pharmaceutical Co., Inc., and the marketers of the Salonpas® line of pain relieving products, announce the availability of the Salonpas® Pain Relief Patch LARGE (SRP: $17.99) in a new double size value pack that includes nine large patches.  The launch is supported by a national broadcast advertising campaign which begins this week.

“There is only one OTC topical pain reliever that is FDA-approved like prescription medicine, and that’s the Salonpas® Pain Relief Patch,” said John Incledon, President & CEO, Hisamitsu America. “We understand that many consumers suffer from back pain, as it is the most common area of pain.  As a response, we decided to launch the new Salonpas® Pain Relief Patch LARGE. They’re twice the size as before with the power to target large pain areas. We also included nine patches in this new product to provide a better value to our consumers. Since the patches are now double the size, there is a 35% savings on an equivalized patch basis.”

“Clinical trials demonstrated that the Salonpas® Pain Relief Patch works up to 12 hours on mild to tougher moderate pain,” said award-winning journalist Dr. Bob Arnot, M.D., internal medicine, who is the author of twelve books on nutrition and health, and previously Chief Medical Correspondent for NBC and CBS News. “As a 70-year old active athlete, I suffer from pain as a result of training and competing. I was a huge fan of the previous Salonpas Pain Relief Patch and it is great that it is now available as a double-size, larger patch which targets my back pain.”

About Hisamitsu America:
Hisamitsu America is the US division of Hisamitsu Pharmaceutical Co., Inc., founded in 1847, which has specialized in transdermal drug delivery system technology since the introduction of its Salonpas line of patches in 1934. The SALONPAS® product line, which gained early acceptance in Asia and now sells in over 30 countries, has pioneered the development of transdermal patches to relieve everyday aches and pains. Today, the Salonpas Pain Relief Patch LARGE is the first and only FDA-approved pain reliever labeled to relieve mild to tougher, moderate pain. For more information, visit www.salonpas.us.

Media Contact:  Nancy Thompson, Vorticom, Inc. 212.532.2208 (o), 917.371.4053 (m); nancyt@vorticom.com

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/3b3f5048-d023-432f-9bee-09dac2421baa

FS-Large-Unsimplified-RGB

Mot-clé